170508 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
THERAPEUTIC AGENT FOR CORONAVIRUS INFECTION
#2CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS
#3NON-SPECIFIC REACTION INHIBITOR, METHOD FOR USING NON-SPECIFIC REACTION INHIBITOR, METHOD FOR INHIBITING NON-SPECIFIC REACTION, BIOCHEMICAL MEASUREMENT REAGENT, SPECIMEN PRETREATMENT SOLUTION, AND BIOCHEMICAL MEASUREMENT REAGENT KIT
#4METHODS FOR TREATING AND REDUCING TRAUMATIC BRAIN INJURY- ASSOCIATED IMPAIRMENTS USING SGP130
#5BIOMARKERS
#6BIOMARKERS FOR ALLERGEN IMMUNOTHERAPY
#7NEUTRALIZATION ANTIBODY ASSAY METHOD
#8Methods of Treating IL1RAP Associated Cancers with Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies
#9METHOD FOR MEASURING CELLULAR UPTAKE OF MOLECULES
#10METHODS RELATING TO IMPAIRED RESPIRATORY HEALTH THERAPEUTICS
#11DECOY CYTOKINE RECEPTOR
#12NOVEL CYTOKINE-BASED THERAPIES AND METHODS
#13REGULATORY T CELL STABILITY ASSAY
#14NITRILOTRIACETIC ACID LINKERS, SOLID PHASE SYNTHESIS OF NITRILOTRIACETIC ACID LINKERS AND APPLICATIONS THEREOF
#15ANTI-IL-4RA ANTIBODIES AND USES THEREOF
#16ANTIBODY VARIANT WITH REDUCED BIOLOGICAL ACTIVITY
#17ASSESSMENT METHODS AND DIAGNOSTIC KIT FOR PREDICTING SUICIDAL BEHAVIORS IN PATIENTS WITH DEPRESSIVE DISORDERS USING MULTIMODAL SERUM BIOMARKERS
#18ANTI-IL13RA2 ANTIBODIES AND USES THEREOF
#19METHOD AND APPARATUS FOR PREPARING PLASMA ENRICHED IN IL-1RA
#20INFORMATIVE BIOMARKERS OF PORTAL HYPERTENSION
#21METHOD FOR PREDICTING IN VIVO PHARMACOKINETICS OF MOLECULE
#22ANTIBODIES TO CANINE AND FELINE ONCOSTATIN M RECEPTOR BETA AND USES THEREOF
#23METHODS OF TREATING MALIGNANT GLIOMAS
#24NOVEL ANTI-IL-36R ANTIBODIES
#25PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#26ANTI IL-36R ANTIBODIES
#27Binding Molecules Targeting IL-2 Receptor
#28Stabilized IL-18 Polypeptides and Uses Thereof
#29EARLY DIAGNOSIS OF INFECTIONS
#30COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNITY, INCLUDING AUTOIMMUNITY ASSOCIATED WITH CANCER AND CANCER THERAPY
#31TREATMENT OF AGING FRAILTY COMPRISING ADMINISTERING BONE MARROW DERIVED MESENCHYMAL STEM CELLS
#32NATURAL KILLER CELL EFFICACY PREDICTION METHOD AND COMPUTING DEVICE
#33ANTI-NR10 ANTIBODY AND USE THEREOF
#34Methods of Predicting Atopic Dermatitis
#35Diagnostic and Treatment of Chronic Pathologies Such as Lyme Disease
#36ANTIBODY AND USE THEREOF FOR THE TREATMENT OF CANCER
#37COMPOSITION FOR DIAGNOSING PANCREATIC CANCER
#38NOVEL SCREENING PLATFORM TO IDENTIFY IMMUNE MODULATORY AGENTS
#39ANTIBODY BINDING HUMAN IL-5R alpha AND USE THEREOF
#40METHODS AND COMPOSITIONS FOR IN SITU IMMUNE PROFILING OF HEART TRANSPLANT BIOPSIES
#41IMMUNOLOGICAL BIOMARKER FOR PREDICTING CLINICAL EFFECT OF CANCER IMMUNOTHERAPY
#42Antibodies Directed Against CD127
#43Biomarkers in Primary Biliary Cholangitis
#44DRUG-SPECIFIC PHARMACOKINETIC ASSAY FOR IL-15 SUPERAGONIST
#45CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS
#46ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR ICHTHYOSIS
#47Identifying Risk of Cerebra Edema
#48ANTIBODY AND USES THEREOF
#49Biomarker for Predicting Prognosis of Radiotherapy for Lung Cancer
#50MITIGATION AND REVERSAL OF INTESTINAL FIBROSIS AND INFLAMMATION BY INHIBITION OF TL1A FUNCTION
#51Compositions and methods for treating age-related diabetes and related disorders
#52IN VITRO METHOD FOR OBTAINING CLINICAL DATA IN PATIENTS SUFFERING FROM AN INFLAMMATORY DISEASE
#53COMPOSITIONS AND METHODS FOR DETECTING ALLERGEN REACTIVE TH2 CELLS
#54Decoy cytokine receptor
#55Early diagnosis of infections
#56Immunological biomarker for predicting clinical effect of cancer
#57Antibodies to canine and feline oncostatin M receptor beta and uses thereof
#58BIOMARKERS FOR DETERMINING SURVIVAL AND THERAPEUTIC RESPONSE IN CERVICAL CANCER
#59Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies and Uses Thereof
#60IL-7R-alpha SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA
#61IL-6 SIGNALING AND BREAST CANCER
#62Anti-IL4 Receptor Antibodies for Veterinary Use
#63Protein signatures for distinguishing between bacterial and viral infections
#64BIOMARKER PANELS FOR ON-TREATMENT PREDICTION OF RESPONSE TO IMMUNO-ONCOLOGY DRUGS
#65Human antibody having high affinity to human IL-4 receptor alpha
#66Compositions and Methods for Discriminating Infectious from Non-Infectious CNS Disorders
#67PREDICTING MORTALITY AND DETECTING SEVERE DISEASE
#68Methods of immunogenic modulation
#69METHODS FOR TREATING AND REDUCING TRAUMATIC BRAIN INJURY- ASSOCIATED IMPAIRMENTS USING SGP130
#70Method for measuring cellular uptake of molecules
#71Selective peptide antagonists
#72Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#73BIOMARKER COMBINATION FOR IDENTIFICATION OF "AT-RISK" SUBJECTS FOR AKI
#74Method For Detecting Bodily Adhesions By Identifying Markers In Circulating Cells
#75Methods of producing an IL-1 RAP antibodies
#76KIT FOR IN VITRO OR EX VIVO MEASUREMENT OF THE EXPRESSION OF sCD127 IN A BIOLOGICAL SAMPLE
#77ANTI IL-36R ANTIBODIES
#78IL-11Rα antibodies
#79Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function
#80Compositions and methods for treating age-related diabetes and related disorders
#81METHODS AND KITS FOR IDENTIFYING EFFECTOR TREG CELLS
#82IL-6 signaling and breast cancer
#83EFFECTOR TYPE REGULATORY T CELL DETECTING METHOD, EFFECTOR TYPE REGULATORY T CELL ANALYZING DEVICE, EFFECTOR TYPE REGULATORY T CELL ANALYZING SYSTEM, AND NON-TRANSITORY STORAGE MEDIUM
#84Test apparatus and methods for ST2 cardiac biomarker
#85Test apparatus and methods for ST2 cardiac biomarker
#86Immunological biomarker for predicting clinical effect of cancer
#87Methods for treating or predicting risk of a ventricular tachyarrhythmia event
#88Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody
#89Use of a CD6 binding partner and method based thereon
#90Decoy cytokine receptor
#91METHODS AND KITS FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO IMMUNOTHERAPY
#92COMPOSITION FOR DIAGNOSIS OF DISEASES
#93IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia
#94Antibodies to IL-15 and uses thereof
#95Early diagnosis of infections
#96Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof
#97DIAGNOSIS OF CARDIOVASCULAR DISEASE
#98Protein signatures for distinguishing between bacterial and viral infections
#99ANTI-IL-6 RECEPTOR ANTIBODY
#100Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy
#101Predicting mortality and detecting severe disease
#102Methods and compositions for treating neurodegenerative and neuroinflammatory conditions
#103Test apparatus and methods for ST2 cardiac biomarker
#104Method of detection of IL1RAP on cells expressing the protein
#105Selective peptide antagonists
#106Methods for detection of markers bladder cancer and inflammatory conditions of the bladder and treatment thereof
#107Method of treatment of leukemia with anti-IL1RAP antibodies
#108Methods of treating a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#109Peptides for blocking IL1RAP protein-protein interaction and uses thereof for treatment of disease
#110Compositions and methods for treating age-related diabetes and related disorders
#111IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia
#112CD127 expression inversely correlates with FoxP3 and suppressive function of CD4 Tregs
#113Predicting risk of major adverse cardiac events
#114Anti-CD3 antibodies, anti-CD123 antibodies and bispecific antibodies specifically binding to CD3 and/or CD123
#115IL1RL-1 as a cardiovascular disease marker and therapeutic target
#116OBSTRUCTIVE SLEEP APNEA (OSA) BIOMARKER PANEL
#117METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE
#118Biomarkers for determining the clinical response to cell therapy
#119METHOD FOR TREATMENT AND PROGNOSIS OF COLORECTAL CANCER
#120Methods of identifying schizophrenia patients at risk for relapse
#121METHOD FOR DIAGNOSING AN INFLAMMATORY DISORDER
#122IL-6 signaling and breast cancer
#123Kit for in vitro or ex vivo measurement of SCD127 expression in a biological sample
#124Anti-human interleukin-1 receptor accessory protein antibody and its use for treating cancer
#125Compositions and methods for expressing polypeptides on the surface of cells
#126Methods of treating cancer using anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies
#127ANTI IL-36R ANTIBODIES
#128Biomarkers and assay to detect chronic graft versus host disease
#129METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#130Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#131Human monoclonal antibodies against CD25
#132Method of treatment for leukemia using an anti-IL1RAP antibody
#133Methods for treating or predicting risk of a ventricular tachyarrhythmia event
#134Use of compounds inhibiting apelin / APJ / GP130 signaling for treating cancer
#135Antibodies to IL-15
#136Predicting mortality and detecting severe disease
#137Antibodies directed against CD127
#138Methods of Treating Cardiovascular Diseases and Predicting the Efficacy of Exercise Therapy
#139Anti-IL-6 Receptor Antibody
#140METHODS AND COMPOSITIONS FOR IMMUNE DIS-INHIBITION
#141Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof
#142Polymerase chain reaction test kits for detecting markers of bladder cancer
#143Interleukin 2 receptor gamma gene targeting vector, production of immune cell-deficient transgenic cloned mini pig having vector introduced therein, preparation method therefor and use thereof
#144Methods of developing selective peptide antagonists
#145Methods of treating or selecting a treatment for a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#146Polynucleotide encoding antibody to human IL-3 receptor alpha chain
#147Ligand Conjugated Quantum Dots for the Detection of Soluble Receptors and Exosomes in Biological Fluids
#148Method for evaluating the risk of mortality in patients who exhibit a systemic inflammatory response syndrome (SIRS) or sepsis
#149Methods and kits for identifying effector Treg cells
#150Test apparatus and methods for ST2 cardiac biomarker
#151Test apparatus and methods for ST2 cardiac biomarker
#152Use of a CD6 binding partner and method based thereon
#153Glatiramer acetate human monocytic cell line-based potency assay
#154METHODS AND USES INVOLVING GENETIC ABERRATIONS OF NAV3 AND ABERRANT EXPRESSION OF MULTIPLE GENES
#155Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway
#156Fibronectin III domain of IL-11Rα
#157EFFECTOR T CELL RSISTANCE
#158IN VITRO METHOD FOR THE DIAGNOSIS AND SURVEILLANCE OF CANCER
#159BIOMARKERS FOR OVARIAN CANCER
#160Methods for predicting the sensitivity of a subject to immunotherapy
#161Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates
#162Human monoclonal antibodies against CD25
#163Gene knock-in non-human animal
#164NANOVECTOR BASED DRUG DELIVERY SYSTEM FOR OVERCOMING DRUG RESISTANCE
#165Compositions and methods for rapid and reversible biomolecular labeling
#166Anti IL-36R antibodies
#167Method of generating antibodies
#168CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ tregs
#169Biomarker of renal dysfunction
#170METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#171Methods for treatment of cardiovascular disease
#172DETERMINATION OF EFFICIENT TIME(S) FOR CHEMOTHERAPY DELIVERY
#173ANTI-NR10 ANTIBODY AND USE THEREOF
#174CANCER PROGNOSTIC ASSAYS
#1751L1RL-1 as a cardiovascular disease marker and therapeutic target
#176Methods and devices for tuberculosis diagnosis using biomarker profiles
#177Treatment of acute myeloid leukemia and myelodysplastic syndromes
#178IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#179Biomarker of renal dysfunction
#180Predicting risk of major adverse cardiac events
#181Process for determining the susceptibility to nosocomial infections
#182BIOMARKERS AND TEST PANELS USEFUL IN SYSTEMIC INFLAMMATORY CONDITIONS
#183PROSTAGLANDIN E2 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#184Soluble ST2 as a marker for risk of mortality in HIV-infected subjects
#185High throughput sensitization detection devices and methods
#186Methods of treating a subject having heart failure
#187IL-11R binding proteins
#188Nucleic acids encoding anti-NR10 antibodies
#189Predicting risk of major adverse cardiac events
#190SOLUBLE ST2 AS A MARKER FOR DISEASE
#191IL-17 HOMOLOGOUS POLYPEPTIDES AND THEREAPEUTIC USES THEREOF
#192NEW METHODS FOR ISOLATING TR1 CELLS
#193Methods predicting risk of an adverse clinical outcome
#194Treating non-hematopoietic cancer with interleukin 6
#195Human monoclonal antibodies against CD25
#196Method for inducing cell death in acute lymphoblastic leukemic system cells
#197TREATMENT OF ONCOSTATIN M RECEPTOR BETA MEDIATED HEART FAILURE
#198Antibody to human IL-3 receptor alpha chain
#199PREDICTING RISK OF MAJOR ADVERSE CARDIAC EVENTS
#200IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#201IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#202METHODS AND USES INVOLVING GENETIC ABERRATIONS OF NAV3 AND ABERRANT EXPRESSION OF MULTIPLE GENES
#203Methods of identifying a subject as having heart failure
#204Inhibiting non-hematopoietic cancer with interleukin 6
#205BIOMARKERS FOR PREDICTING SUSTAINED RESPONSE TO HCV TREATMENT
#206BIOMARKER
#207Methods for treatment of cardiovascular disease
#208Predicting mortality and detecting severe disease
#209IL1RL-1 as a cardiovascular disease marker and therapeutic target
#210Anti-IL-6 Receptor Antibody
#211Anti-NR10 antibody and use thereof
#212ANTI-NR10 ANTIBODY AND USE THEREOF
#213USE OF IMMUNOREGULATORY NK CELL POPULATIONS FOR PREDICTING THE EFFICACY OF ANTI-IL-2R ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS
#214IRAK-1 AS REGULATOR OF DISEASES AND DISORDERS
#215IL1RL-1 as a cardiovascular disease marker and therapeutic target
#216Kit comprising an antibody to interleukin 17 receptor-like protein
#217Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
#218Methods of predicting steroid responsiveness with Il-1RII
#219Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
#220Diagnosis of cardiovascular disease
#221Predicting risk of major adverse cardiac events
#222Methods for diagnosis of cardiovascular disease
#223Human monoclonal antibodies against CD25
#224Methods and compositions for correlating genetic markers with multiple sclerosis
#225IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#226CD127 expression inversely correlates with FoxP3 and suppressive function of CD4Tregs
#227GRP78 targeting peptides and methods employing same
#228Predicting mortality and detecting severe disease
#229IL-17 receptor-like polypeptides and therapeutic uses thereof
#230IL1RL-1 as a cardiovascular disease marker and therapeutic target
#231Compositions and methods of use of targeting peptides for diagnosis and therapy
#232Methods for diagnosis of cardiovascular disease